- Home
- WKHS vs TARA Comparison
WKHS vs TARA Comparison
Compare WKHS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- TARA
- Stock Information
- Founded
- WKHS 2007
- TARA N/A
- Country
- WKHS United States
- TARA United States
- Employees
- WKHS N/A
- TARA N/A
- Industry
- WKHS Auto Manufacturing
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WKHS Consumer Discretionary
- TARA Health Care
- Exchange
- WKHS Nasdaq
- TARA Nasdaq
- Market Cap
- WKHS 44.3M
- TARA 52.4M
- IPO Year
- WKHS N/A
- TARA N/A
- Fundamental
- Price
- WKHS $0.81
- TARA $5.16
- Analyst Decision
- WKHS Sell
- TARA Strong Buy
- Analyst Count
- WKHS 3
- TARA 3
- Target Price
- WKHS $5.75
- TARA $22.67
- AVG Volume (30 Days)
- WKHS 2.7M
- TARA 6.6M
- Earning Date
- WKHS 11-19-2024
- TARA 11-12-2024
- Dividend Yield
- WKHS N/A
- TARA N/A
- EPS Growth
- WKHS N/A
- TARA N/A
- EPS
- WKHS N/A
- TARA N/A
- Revenue
- WKHS $9,097,780.00
- TARA N/A
- Revenue This Year
- WKHS N/A
- TARA N/A
- Revenue Next Year
- WKHS $247.90
- TARA N/A
- P/E Ratio
- WKHS N/A
- TARA N/A
- Revenue Growth
- WKHS N/A
- TARA N/A
- 52 Week Low
- WKHS $0.57
- TARA $1.60
- 52 Week High
- WKHS $8.18
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- WKHS 36.58
- TARA 60.39
- Support Level
- WKHS $0.99
- TARA $5.27
- Resistance Level
- WKHS $1.26
- TARA $6.39
- Average True Range (ATR)
- WKHS 0.09
- TARA 0.91
- MACD
- WKHS -0.04
- TARA 0.03
- Stochastic Oscillator
- WKHS 0.00
- TARA 33.50
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).